Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Critical Care

    Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the Intensive Care Unit.

  • Hospital Care

    From the pharmacy to the bedside, we help you increase safety, streamline processes and build cost efficiency throughout the hospital.

  • Nutritional Care

    Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.

  • Renal Care

    Pioneering innovation in haemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.

  • Surgical Care

    Delivering innovative surgical products that help you operate with confidence, precision and speed.

  • Our Products

    Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives
  • Patients' Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Healthcare Insights

    We’re engaging with industry thought leaders to explore how science and innovation advance healthcare.

  • Community Engagement

    Enriching the communities where we live and work.

  • People of Baxter

    Our organization is enriched by a diverse population of individuals that work together to drive better healthcare options for patients around the world.

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Commitment to Ireland

    Our presence in Ireland for more than 50 years

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fuelling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • Critical Care

    When every moment counts, our therapies help healthcare professionals provide life-sustaining treatment to you or your loved ones.

  • Hospital Care

    From the pharmacy to the bedside, we support you and your healthcare providers with intravenous medications and infusion technologies designed with safety in mind.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we work with your healthcare provider to help you regain or maintain your health, through life-saving clinical nutrition options.

  • Renal Care

    Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, we are with you and your healthcare provider, every step of the way, providing options to meet your lifestyle needs.

  • Surgical Care

    We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.

  • Empowering Patients

    We work in partnership with HSE organisations to enable you to self-care and manage your therapy at home.

Baxter Increases Dividend and Declares Quarterly Dividend

Press Release

PDF

DEERFIELD, Ill. -

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company’s quarterly cash dividend to a rate of $0.245 per share of common stock. This represents an approximately 11% increase over the previous quarterly dividend rate of $0.22 per share. Baxter’s Board of Directors declared the dividend payable on July 1, 2020, to stockholders of record as of June 5, 2020. The indicated annual dividend rate is now $0.98 per share of common stock. 

"Baxter's disciplined capital allocation strategy is focused on driving innovation and increased access for patients, growth for the business, and enhanced value for our investors," said José (Joe) E. Almeida, chairman and chief executive officer. "The company's ongoing transformation has strengthened our financial position and allowed us to annually increase our quarterly dividend rate for the fifth straight year."

About Baxter

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com.

This release includes forward-looking statements concerning the company's capital allocation, which currently includes the issuance of quarterly dividends. These forward-looking statements are based on assumptions about many factors and it is possible that Baxter’s annual dividend payout rate may differ, possibly materially, from the anticipated annual indicative dividend described herein. For information about some of the risks and important factors that could affect Baxter's future results, financial condition and liquidity, see Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws.

Baxter is a registered trademark of Baxter International Inc.